To hear about similar clinical trials, please enter your email below
Trial Title:
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
NCT ID:
NCT06261684
Condition:
Plantar Wart
Conditions: Official terms:
Warts
Foot Diseases
Acyclovir
Study type:
Interventional
Study phase:
Phase 2/Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Double (Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Drug
Intervention name:
Intralesional Acyclovir
Description:
Intralesional Acyclovir in plantar warts
Arm group label:
Intralesional Acyclovir
Intervention type:
Device
Intervention name:
Cryotherapy
Description:
Cryotherapy of plantar warts
Arm group label:
Cryotherapy
Summary:
The goal of this prospective randomized controlled study is to study the safety and
efficacy of intralesional acyclovir compared to cryotherapy in plantar warts. The main
questions needed to be answered are:
1. Is Intralesional acyclovir safe for plantar warts?
2. Is Intralesional acyclovir more efficient in treating plantar warts compared to
cryotherapy?
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients aged 18 years or older, of both genders, with plantar warts
Exclusion Criteria:
- Patients on systemic treatment for warts eg. Acitretin, Acyclovir
- Hypersensitivity to Acyclovir
- Previous treatment to the same wart during the last 3 months
- Immunocompromised patients (as HIV, steroid intake, uncontrolled diabetes, etc.)
- Pregnant and breastfeeding females
- Cognitively impaired patients
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Cairo University Hospital
Address:
City:
Cairo
Country:
Egypt
Status:
Recruiting
Contact:
Last name:
Basant Helal, MRCP
Investigator:
Last name:
Shahira Ramadan, Professor
Email:
Principal Investigator
Investigator:
Last name:
Yousra Azzazi, Lecturer
Email:
Sub-Investigator
Start date:
October 1, 2023
Completion date:
October 1, 2024
Lead sponsor:
Agency:
Cairo University
Agency class:
Other
Source:
Cairo University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06261684
